Article

Third oral agent for ED wins FDA approval

The FDA has approved tadalafil (Cialis), a new oral PDE-5 inhibitor, for the treatment of erectile dysfunction.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

© 2025 MJH Life Sciences

All rights reserved.